Data Collection of Normal Tissue Toxicity for Proton Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00991094|
Recruitment Status : Recruiting
First Posted : October 7, 2009
Last Update Posted : February 21, 2018
The goal of this research study is to collect information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself so that researchers can develop methods to predict the risk of side effects for future patients.
This is an investigational study. Researchers expect to have about 5,000 patients on the study. All the patients will be enrolled at MD Anderson.
|Condition or disease|
As part of your standard of care, you will be examined by your doctor weekly during your routine proton therapy and then 1-3 more times up to 90 days from the start of treatment and then at least once a year after that.
Also as part of your standard of care, certain standard laboratory blood and/or urine test and/or radiologic tests will be done to check if the tumor is under control and to look for any side effect of the treatment.
If you agree to take part in this study, all of the information collected during your visits as well as detailed information on the proton treatment plan will be gathered and stored in a computer for future analysis.
You will fill out quality-of-life questionnaires that should take about 15-20 minutes to complete.
|Study Type :||Observational|
|Estimated Enrollment :||5000 participants|
|Official Title:||Data Collection to Assess Acute and Late Normal Tissue Sequelae in Proton Therapy for Adults|
|Actual Study Start Date :||May 2005|
|Estimated Primary Completion Date :||September 2019|
|Estimated Study Completion Date :||September 2020|
Collection of normal-tissue toxicity data and symptom data during and after clinical proton treatment at University of Texas MDACC and of the corresponding proton dose distribution data.
- Acute and Late Toxicities Data (including second malignant neoplasms) [ Time Frame: 5 Years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00991094
|Contact: Steven J. Frank, MD||713-563-2300|
|United States, Texas|
|University of Texas MD Anderson Cancer Center||Recruiting|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Steven J. Frank, MD||M.D. Anderson Cancer Center|